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Abstract
Background: The deletion of the chromosome 4p16.3 Wolf-Hirschhorn syndrome critical region (WHSCR-2) typically
results in a characteristic facial appearance, varying intellectual disability, stereotypies and prenatal onset of growth
retardation, while gains of the same chromosomal region result in a more variable degree of intellectual deficit and
dysmorphism. Similarly the phenotype of individuals with terminal deletions of distal chromosome 3p (3p deletion
syndrome) varies from mild to severe intellectual deficit, micro- and trigonocephaly, and a distinct facial appearance.
Methods and results: We investigated a large Indian five-generation pedigree with ten affected family members in
which chromosomal microarray and fluorescence in situ hybridization analyses disclosed a complex rearrangement
involving chromosomal subregions 4p16.1 and 3p26.3 resulting in a 4p16.1 deletion and 3p26.3 microduplication in
three individuals, and a 4p16.1 duplication and 3p26.3 microdeletion in seven individuals. A typical clinical presentation
of WHS was observed in all three cases with 4p16.1 deletion and 3p26.3 microduplication. Individuals with a 4p16.1
duplication and 3p26.3 microdeletion demonstrated a range of clinical features including typical 3p microdeletion or
4p partial trisomy syndrome to more severe neurodevelopmental delay with distinct dysmorphic features.
Conclusion: We present the largest pedigree with complex t(4p;3p) chromosomal rearrangements and diverse clinical
outcomes including Wolf Hirschorn-, 3p deletion-, and 4p duplication syndrome amongst affected individuals.
Keywords: Wolf–Hirschhorn syndrome, WHS, Complex rearrangement of chromosome 4p16, 3p deletion syndrome,
4p partial trisomy syndrome, Mental Retardation, Developmental delay
Background
Microscopically visible rearrangements of chromosome
4p16 may result in two separate syndromes: Wolf–
Hirschhorn syndrome (WHS) and partial trisomy 4p
syndrome. WHS is a well-recognized contiguous gene
deletion syndrome associated with prenatal and post-
natal growth delay, a typical ‘Greek warrior helmet’ ap-
pearance of the nose, microcephaly, and neurological
features including seizures, hypotonia and varying degrees
of intellectual impairment [1]. In contrast, 4p16 duplica-
tion results in partial trisomy 4p syndrome, which gives
rise to variable clinical manifestations including intellec-
tual disability, developmental delay and distinctive facial
features [2–4].
About 40–45 % of the WHS cases involve an unbal-
anced translocation and a deletion of 4p as well as partial
trisomy of a different chromosome arm [5]. These unbal-
anced translocations may be de novo, or inherited from a
parent with a balanced chromosomal rearrangement. Dif-
ferent rearrangements of chromosome 4p causing WHS
and partial trisomy 4p syndrome in the same family have
been reported [2–4, 6], as have a few reports of isolated
unbalanced translocation involving chromosomes 4 and 3
[7–10]. The size of the chromosomal rearrangement and
clinical presentations vary in these cases. Terminal and
interstitial deletions of the short arm of chromosome 3
* Correspondence: v.alakbarzade@exeter.ac.uk; a.h.crosby@exeter.ac.uk
†Equal contributors
2Molecular Genetics, RILD Institute, University of Exeter, Royal Devon and
Exeter NHS Hospital, Wonford, Exeter, UK
Full list of author information is available at the end of the article
© 2015 Iype et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Iype et al. BMC Medical Genetics  (2015) 16:104 
DOI 10.1186/s12881-015-0251-5
comprises another contiguous gene deletion syndrome
(3p deletion syndrome), which may also present with a
variable clinical phenotype and associated with a number
of different causal deletions. The core features of the
syndrome typically include cognitive handicap, growth
retardation, microcephaly, and facial dimorphism (ptosis,
downslanting palpebral fissures and micrognathia), while
variable features include congenital heart defects, postaxial
polydactyly, cleft palate, renal and intestinal anomalies
[11, 12]. In this report, we document a large Indian
pedigree in which individuals have inherited varying
combinations of an unusual chromosomal transloca-
tion involving chromosome 4p16 and a small section
of chromosome 3p26.3, resulting in a range of clinical
phenotypes including Wolf–Hirschhorn syndrome, 4p
partial trisomy- and 3p deletion syndrome.
Methods and results
Study approval
The present studies were reviewed and approved by
the senior investigators from Banaras Hindu University,
Varanasi, UP and Medical College, Trivandrum, Kerala
and Royal Devon & Exeter NHS Foundation Trust. All
tissue samples were taken with informed consent in ac-
cordance with all ethical standards and protocols. The
ethical clearance number is EC/847 and EC registration
No. ECR/526/INSt/UP2014. All subjects or their guardians
provided informed consent prior to their participation in
the study and for publishing this research article. Written
parental consent also was obtained to publish any images
of minors. Written informed consent was obtained to pub-
lish the photographs of affected individuals.
Clinical report
The family, from Kerala (South India), comprises a total of
36 members over five generations (Fig. 1). All 10 affected
subjects were evaluated by a neurologist and a clinical
geneticist. Pregnancy and delivery of 9/10 affected individ-
uals was uncomplicated, with delivery at gestational age
38 weeks while IV:11 was born pre-term. Patient clinical
data and findings are summarized in Tables 1 and 2.
V:1 (born in 2000) and V:2 (born in 2004) are the only
affected siblings in generation V of the pedigree. Birth
weight was 1.5 kg in both cases, length and head circum-
ference at birth were not reported. V:1 was floppy at
birth, and developed severe physical and psychomotor
developmental delay (sitting at 4 years, currently can only
stand with support, delayed or poor eye contact and no
speech). A past history of febrile seizures and status epi-
lepticus is reported. Stereotypies of recent onset included
Fig. 1 Left panel: family pedigree including an illustration of the chromosome 3 and 4 al rearrangement detected. Right panel: normal
chromosome 3 telomere, demarcated with green circle (a) and normal chromosome 4 telomere, with red circle (b). A balanced translocation
outcome is shown in c, while unbalanced translocation outcomes are shown in d (3p duplication and 4p deletion) and e (3p deletion,
4p duplication)
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rocking and repeated hand washing. Dysmorphic facial
features were noted (Table 1; Additional file 1: Figure S1)
as well as hand malformations including tapering-long
fingers, bilateral inability to abduct the thumb, single trans-
verse palmar crease, hypermobile metacarpophalangeal
joints of thumb, overlapping fingers and pes planus.
Neurological examination at 12 years of age revealed:
increased tone and reflexes in lower limbs. At the age
of 12 she developed stereotypic body movements such
as bending from side to side, body rocking and hand
washing. The younger sibling (V:2) required ventilation
for a month post-delivery. Developmental milestones were
delayed, walked with support at age 2. Speech is limited
to a few words and she is unable to read and write.
Generalised tonic-clonic seizures developed at 17 months.
Unilateral agenesis of the kidney was seen on ultrasound.
Additional clinical features included sacral dimple,
overlapping and tapered fingers, flexion contracture of
proximal interphalangeal joints, inability to abduct the
thumb, simian hand line, hypermobile metocarpopha-
langeal joint of thumb, rocker bottom feet, prominent
talus, medial malleolus, ear deformities (left preauricular
sinus, small ears with small lobule, ‘cauliflower’ shaped left
ear and pointed pinna). Neurological examination con-
ducted at age 8 revealed left lower motor neuron facial
palsy, reduced tone (upper limbs), and increased tone
in the lower extremities with exaggerated reflexes. MRI
imaging of the brain showed hypo-dense lesions in
frontal lobes.
IV:13 is a maternal cousin of siblings V:1 and V:2. His
birth weight was 1.8 kg. Developmental concerns were
noted early on and progress was similar to V:1. At the
age of 2 he had not developed speech and walking, could
sit with support and independently roll from back to
front. He developed epilepsy with generalized tonic-clonic
seizures at 12 months, which is currently under control on
phenytoin. He also has swallowing difficulties, drooling
and urinary incontinence. He responds to noise, and rec-
ognizes his parents. Behavioral problems include self-
harm and stereotypies including body rocking movements.
Facial features are as described in Table 1 and ear and limb
deformities resembling those of V:2. Additional findings
included: strabismus, a high arched palate, cleft lip, fixed
flexion deformity of the elbows, flat occiput and widely
spaced nipples. Neurological examination revealed gener-
alized hypotonia, brisk reflexes and out-turned feet. Ultra-
sonography revealed kidney malformation, and brain MRI
revealed dysgenesis of the corpus callosum.
Individual IV:11 was born pre-term (birth weight 1.2 kg)
to consanguineous parents. He had severe developmental
delay with no speech and walked with support at age 3.
He responds to sounds but hearing function has not been
tested. He has a history of surgically treated cleft lip and
complex partial seizures. On neurological examination
he had gaze evoked nystagmus, limb ataxia, gait ataxia;
exaggerated knee and ankle jerks and up-going plantar
reflexes. The dysmorphic features are described in Table 2
and Additional file 1: Figure S1. Additional findings on
examination were sacral dimple, strabismus and hypospa-
dius. Behavioral abnormalities included stereotypies in-
cluding rocking, hand wringing, repeated hand washing,
head banging and self-harm.
III:4 was the eldest affected child of the third generation.
She had no speech or walk until age 2 and has medically
resistant secondarily generalized tonic-clonic seizures. At
the time of assessment she could not walk unaided, her
speech was dysarthric with limited vocabulary and she was
unable to read or write. Neurological examination revealed
kyphosis, reduced upper limb deep tendon reflexes, absent
knee and ankle jerk, hypotonia, scanning speech, gaze
evoked nystagmus, and an ataxic gait. Facial features were
as described in Table 2. Her daughter, IV:2, started to walk
at age 3 and speak at age 4. She displayed aggressive be-
havior and had mild intellectual impairment. Neurological
examination revealed absent knee and ankle jerks and
dysarthria. No history of seizures was reported, and dis-
tinctive dysmorphic features were noted (Table 2).
IV:17 was born to consanguineous parents. Apart from
mild learning difficulties and limited vocabulary, no neuro-
logical or other physical abnormalities were detected
on examination.
Table 1 Clinical presentation of the three patients with the
chromosomes 4p16 deletion and 3p26.3 duplication
V:1 V:2 IV:13
Age 12.5 8.8 12
Gender F F M
Growth Parameters
Height (cm/SDSa) 109 /-5.9 110 /-5.3 128 /-0.3
Head circumference (cm/SDSa) 43 /-8.8 42 /-8.0 48 /-4.2
Severe mental retardation + + +
Facial features of WHS::
• High arched eyebrows + + +
• Broad flat nasal bridge + + +
• Prominent nasal tip + + +
• Prominent eyes + + +
• Ocular hypertelorism + + +
• Short philtrum + + +
• Downturned mouth + + +
• Micrognathia + + +
Seizures - + +
Prenatal growth delay + + +
Hypotonia + + +
aSDS standard deviation score (http://www.who.int/childgrowth/standards/en/);
above (−2 SDS) normal average
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Table 2 Clinical presentation of the seven patients with chromosomes 4p16.1 duplication and 3p26.3 microdeletion
Case III:4 IV:8 IV:9 IV:2 IV:11 IV:1 IV:17
Age 40 20.5 16.7 16.1 14.1 11.7 7.9
Sex F M M F M M F
Developmental delay + + + - + + +
Intellectual disability Severe Mild Mild Mild Severe Mild Mild
Height (cm/SDS) 157/-1.1 179/0.2 172/-0.4 151/-2.0 130/-3.8 143/-0.3 122/-0.4
Head circumference
(cm/SDS)
52/-2.5 55/-1.3/Mild 53.5/-1.9/ 53/-1.7 49/-4.1/ 51/-2.4/ 51/-1.5
Shape NAD Brachycephaly Brachycephaly NAD Trigonocephaly Brachycephaly NAD
Facial features Prominent supraorbital
ridges & glabella; prominent
midface; prognathism
Mild prominence
supraorbital ridges &
glabella
Prominent supraorbital
ridges & glabella; prominent
midface; mild prognathism
Mild prominence of supraorbital
ridges & glabella; prominent
midface; prognathism
Hypertelorism, Prominent
midface; Flat broad nasal
tip, low hanging columella
NAD NAD
Highly arched eyebrows
Low frontal and nuchal
hair line
Nose Prominent nasal tip Prominent nasal tip Prominent nasal tip Prominent nasal tip Broad high nasal bridge Flat nasal
bridge
NAD
Prominent nasal tip
Mouth Thin vermillion of the
upper lip; High arched
palate; cleft lip; gum
hypertrophy
NADa High arched palate NAD Short philtrum NAD NAD
Cleft lip
Ears Strabismus Low set ears Prominent ears, malformed
helix
Prominent, low set ears Low set ears; malformed
helix
Low set ears NAD
Hand deformity Campodactyly Campodactyly Long digits NAD Campodactyly Clindactily NAD
Feet deformity Pes cavus; inversion deformity
of feet
Seizures + -b - - + - -
aNAD- no abnormality detected; b- no seizures
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IV:8, IV:9 and IV:1 had delayed walking and speech at
2.5 – 3 years, and similar levels of mild learning difficul-
ties. The birth weight of only IV:8 was documented
(2.5 kg). Individual IV:8 could never run due to poor
balance, and although he went to a school up to tenth
grade, his intellectual abilities are limited. On neuro-
logical examination had mild upper and lower motor
neuron signs, ataxia and could not stand on his heels.
Brain MRI revealed mild cerebral atrophy. Case IV:9 had
a previous history of lumbar discectomy. All the ob-
served phenotypic abnormalities are described in Table 2
and Additional file 1: Figure S1.
Microarray analysis and flourescent in situ hybridization
(FISH)
DNA samples from family members were genotyped
using the Illumina HumanCytoSNP-12 v2.1 microarrays to
detect copy-number variations (CNVs). The Illumina Infi-
nium HD assay protocol was followed and the array proc-
essed on a BeadStation 500G. Image data was processed in
the Illumina GenomeStudio software to generate genotype
calls, B allele frequency and logR ratio values. These were
further analysed for CNVs using Illumina’s KaryoStudio
software. This revealed a 3p26.3 (0–2144867)x3duplication
and 4p16.3-16.1 (0–10308871)x1 deletion in three affected
individuals (IV:13; V:1; V:2), and a reciprocal 3p26.3 (0–
2118422)x1deletion and 4p16.3-16.1 (0–10290552)x3dupli-
cation in seven affected individuals (III:4; IV:8; IV:9; IV:2;
IV:11; IV:1; IV:17), including two (III:4 and IV:11) with
more severe phenotype than others (Additional file 1: Table
S1, Figure S1 and Figure S2). For FISH, Kreatech probes
D4S33060 and D3S4558 were used to define either bal-
anced or unbalanced t(3p;4p) translocations in three indi-
viduals, case V:2, IV:9 and III:3 on whom samples were
available for study (Additional file 1: Figure S3).
Discussion and conclusions
We describe a complex reciprocal translocation involving
chromosomes 3 and 4 in ten affected family members of a
five-generation pedigree, resulting in clinical manifestations
of 3 rare chromosomal syndromes. This is, to our know-
ledge, the first reported case study of a chromosomal
imbalance that combines chromosome 4p deletion (WHS),
4p partial trisomy and 3p deletion syndromes in the same
family. Nine of the 10 affected family members (II:2; III:7;
III:10; III:12; III:14; III:17 and IV:4) were born from a
healthy parent with a balanced translocation of chromo-
somes 3 and 4, while a single affected individual (IV:2)
inherited her imbalanced chromosomal complement from
her affected mother (III:4) who herself displayed the same
4p16.1 duplication and 3p.26.3 microdeletion.
Deletion of the chromosome 4p region has previously
been shown to result in a widely recognized phenotype
compared with gains of the same region, which result in
more variable clinical manifestations. The family described
here includes three family members with chromosome 4p
deletion resulting in WHS, all of whom displayed the typ-
ical clinical features of this condition. The characteristic
phenotype of WHS includes a typical facial appearance, sig-
nificant intellectual disability and poor growth [13]. The
high arched eyebrows and prominent nasal tip that were
seen in all three WHS cases described here may relate to
the progression of these facial features with age, as has been
previously suggested [1]. Similarly, the ear hand and feet
anomalies, and dysgenesis of corpus callosum, have previ-
ously been documented in WHS cases [1, 14].
At a molecular level, within the terminal 1.9 Mb region
on 4p16.3, Wolf-Hirschhorn syndrome candidate region 2
(WHSCR-2) was described as the likely critical region for
WHS [15]. Candidate genes in that region have been sug-
gested to cause particular clinical aspects of WHS [16, 17].
Haploinsufficiency of the WHSC1 gene [OMIM 602952],
which is disrupted by the proximal breakpoint of WHSCR-
2, has been associated with both facial characteristics and
growth delay [18, 19]. The LETM1 gene, residing entirely
within WHSCR-2, is considered to play an important
role in the pathogenesis of seizures [20–24]. However,
genotype–phenotype correlation analyses suggested that
haploinsufficiency of LETM1 alone may not be sufficient
in causing seizures and that loss of the terminal 1.5 Mb
region with breakpoint at ~300 kb from the LETM1
locus, preserving LETM1, is critical for the development
of a seizure disorder [25]. Large deletions of chromosome
4p16 incorporating both critical regions are typically asso-
ciated with profound intellectual disability, seizures and
psychosis in addition to the typical facial appearance
[15, 18, 19]. Our microarray analysis of the three WHS
cases described here with 4p16.3-16.1 deletion and
3p26.3 duplication identified a ~5 Mb deletion encom-
passing WHSCR-2 which resulted in severe developmen-
tal delay with absent (2/3) or impaired speech (1/3),
absent (2/3) or significantly delayed onset of walking
(1/3), as well as generalized tonic-clonic seizures (3/3)
and behavioral abnormalities (2/3), consistent with
those previously described in WHS.
Compared to the classical presentation seen in the
three WHS patients, the seven chromosome 4p partial
trisomy patients displayed a much more variable clinical
picture. The degree of intellectual deficit present across
the seven cases varied from severe (2/7) to mild (4/7).
The majority of the seven patients displayed clinical fea-
tures previously described for trisomy of 4p syndrome,
including prominent supraorbital ridges (5/7), promin-
ent nasal tip (5/7), prognathism (3/7), camptodactyly (2/
7) and malformed and low-set ears (5/7). Although head
circumference was reduced in all seven cases, height was
variable ranging from normal (5/7) to short stature (2/7)
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(Table 2). Overexpression or inactivating mutations of
two genes mapping to the chromosomal region involved,
fibroblast growth factor receptor 3 (FGFR3) and WHSC1,
have been reported to be associated with overgrowth fea-
tures such as macrocephaly, campodactyly and tall stature
[26, 27]. FGFR3 is a physiological negative regulator of
bone growth, and has been associated with syndromic pre-
sentations affecting bone growth including the overgrowth
syndrome-CATSHL (campodactyly, tall stature, and hear-
ing loss) [26]. Similarly, overexpression of WHSC1 has
been suggested as a contributor to the overgrowth seen
as part of this condition. In mice, haploinsufficency of
WHSC1 resulted in growth retardation [27]. Two of the
7 chromosome 4p duplication cases (III:4 and IV:11)
demonstrated discordant clinical manifestations including
severe intellectual disability, short stature, microcephaly,
generalized tonic-clonic seizures, gum hypertrophy and
cerebellar signs, compared with relatively mild learning
difficulties in the remaining five cases (IV:8; IV:9; IV:2;
IV:1 and IV:17). The cerebellar signs and gum hypertrophy
seen in the 2 severely affected cases may relate to long
term phenytoin treatment.
The craniofacial features observed in 1 of the 2 partial
4p trisomy cases (IV:11), including high arched eye brows,
hypertelorism, trigonocephaly as well as marked reduction
in growth milestones and behavioral changes, are not previ-
ously recognized in partial 4p trisomy syndrome (Table 2;
& Additional file 1: Figure S1). While this may reflect as-yet
unrecognized clinical variability in this disorder, it is more
likely to be due to the complexity of the chromosome
imbalance in these cases.
The chromosome 3pter rearrangement defined here
is somewhat smaller compared with rearrangements
previously reported as part of chromosome 3p duplication
syndrome. The 2.7 Mb chromosome 3 microdeletion de-
tected in this family includes the CNTN4 and CHL1 genes,
which have previously been shown to have a pleotropic
effect and contribute to learning difficulties in affected
individuals [28–33]. Further, CNTN4 deletion has been
associated with microcephaly, trigonocephaly, hypertelor-
ism, growth retardation and ear abnormalities. However
these clinical features were present in only two of the
seven chromosome 3p26.3 microdeletion cases (III:4 &
IV:11) presented here. This may mean that other factors
including age of examination, other genes in the 3pter re-
gion, epigenetic phenomena, expression or regulatory vari-
ation and the unmasking of recessive variants residing on
the other unperturbed allele, may also be required for the
development of these features.
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